ACRV — Acrivon Therapeutics Inc
Acrivon Therapeutics Inc (ACRV) is listed on NASDAQ.
ACRV belongs to the HEALTHCARE sector and the BIOTECHNOLOGY industry.
To answer "what is ACRV worth" or "what is happening with Acrivon Therapeutics Inc", VAQO shows a live price alongside technical analysis, relevant headlines and what other investors think.
VAQO's learning model reads seven technical indicators — short and long momentum, RSI, volatility, volume ratio, moving-average cross and position in the 52-week range — and turns them into transparent opportunity and risk scores.
What ACRV is
Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of precision cancer medicines. The company is headquartered in Watertown, Massachusetts.…
Acrivon Therapeutics Inc is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.
It trades on NASDAQ as a common stock.
ACRV size and valuation
At roughly $80.6M, ACRV is a micro-cap.
Earnings per share are negative at -1.88, so there is no meaningful price-to-earnings multiple to quote.
Beta is 1.93: historically it has moved more than the market.
ACRV over the past year
Over the past year ACRV has traded between $1.27 and $3.56, and the current price sits at 15% of that range.
Trading near the low end of a 52-week range is a different situation from a bad day: it means the year, not the session, has gone against it.
The 50-day average is $1.94 against a 200-day average of $1.81 — the shorter average sits above the longer one, the configuration usually read as an uptrend.
The published analyst target is $11.50, 614.3% above it. A target is an aggregate of opinions, not a measurement.
How Acrivon Therapeutics Inc (ACRV) is trading
Acrivon Therapeutics Inc (ACRV) is up 2.55% at $1.61 — a more volatile session than average.
The session ranged from $1.50 to $1.70 — 12.4% of the share price — and the current price sits at 55% of that range.
It opened at $1.50 against a previous close of $1.57 — an opening gap of -4.5%, which almost always comes from information released outside trading hours.
Volume ran near 364.5K shares, about $586.9K of stock changing hands.
Traded alongside ACRV
Names traded alongside ACRV in the same sector: A (Agilent Technologies Inc), AAPG (Ascentage Pharma Group International), AARD (Aardvark Therapeutics Inc), ABCL (AbCellera Biologics Inc), ABEO (Abeona Therapeutics Inc).
What VAQO's model says about ACRV
Two statistical models run over ACRV inside the browser, reporting momentum, risk and opportunity separately. Full accuracy for both, including when it falls, is published on the model page.
ACRV at a glance
- Symbol: ACRV
- Name: Acrivon Therapeutics Inc
- Sector: HEALTHCARE
- Industry: BIOTECHNOLOGY
- Exchange: NASDAQ
- Instrument: Stock
ACRV — frequently asked questions
What is the market cap of ACRV?
Acrivon Therapeutics Inc has a market capitalisation of roughly $80.6M.
What is the 52-week range for ACRV?
ACRV has traded between $1.27 and $3.56 over the past year, with the current price at 15% of that range.
How much does ACRV stock cost today?
Acrivon Therapeutics Inc (ACRV) trades at $1.61, a change of +2.55% in the latest session.
Is ACRV up or down today?
ACRV is up 2.55% in the latest session, at $1.61.
What is the daily trading range for ACRV?
ACRV traded between $1.50 and $1.70 in the latest session, and currently trades at $1.61.
What is the trading volume for ACRV?
ACRV traded roughly 364.5K shares in the latest session.
Which exchange is ACRV listed on?
ACRV is listed on NASDAQ, in the HEALTHCARE sector.
Should I buy ACRV stock?
VAQO gives no buy or sell recommendations and is not an investment adviser. The ACRV figures on this page — price, range, volume and the model's scores — are there to inform your decision, not to stand in for it.
Traded alongside ACRV
- A — Agilent Technologies Inc
- AAPG — Ascentage Pharma Group International
- AARD — Aardvark Therapeutics Inc
- ABCL — AbCellera Biologics Inc
- ABEO — Abeona Therapeutics Inc
- ABOS — Acumen Pharmaceuticals Inc
Last updated: 2026-11-08